Reza Averly


2025

pdf bib
LIDDIA: Language-based Intelligent Drug Discovery Agent
Reza Averly | Frazier N. Baker | Ian A Watson | Xia Ning
Proceedings of the 2025 Conference on Empirical Methods in Natural Language Processing

Drug discovery is a long, expensive, and complex process, relying heavily on human medicinal chemists, who can spend years searching the vast space of potential therapies. Recent advances in artificial intelligence for chemistry have sought to expedite individual drug discovery tasks; however, there remains a critical need for an intelligent agent that can navigate the drug discovery process. Towards this end, we introduce LIDDiA, an autonomous agent capable of intelligently navigating the drug discovery process in silico. By leveraging the reasoning capabilities of large language models, LIDDiA serves as a low-cost and highly-adaptable tool for autonomous drug discovery. We comprehensively examine LIDDiA, demonstrating that (1) it can generate molecules meeting key pharmaceutical criteria on over 70% of 30 clinically relevant targets, (2) it intelligently balances exploration and exploitation in the chemical space, and (3) it identifies one promising novel candidate on AR/NR3C4, a critical target for both prostate and breast cancers. Code and dataset are available at https://github.com/ninglab/LIDDiA.

pdf bib
Entity Decomposition with Filtering: A Zero-Shot Clinical Named Entity Recognition Framework
Reza Averly | Xia Ning
Proceedings of the 2025 Conference of the Nations of the Americas Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers)

Clinical named entity recognition (NER) aims to retrieve important entities within clinical narratives. Recent works have demonstrated that large language models (LLMs) can achieve strong performance in this task. While previous works focus on proprietary LLMs, we investigate how open NER LLMs, trained specifically for entity recognition, perform in clinical NER. Our initial experiment reveals significant contrast in performance for some clinical entities and how a simple exploitment on entity types can alleviate this issue. In this paper, we introduce a novel framework, entity decomposition with filtering, or EDF. Our key idea is to decompose the entity recognition task into several retrievals of entity sub-types and then filter them. Our experimental results demonstrate the efficacies of our framework and the improvements across all metrics, models, datasets, and entity types. Our analysis also reveals substantial improvement in recognizing previously missed entities using entity decomposition. We further provide a comprehensive evaluation of our framework and an in-depth error analysis to pave future works.